Qiang Song

520 total citations · 1 hit paper
13 papers, 375 citations indexed

About

Qiang Song is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Qiang Song has authored 13 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Qiang Song's work include Ferroptosis and cancer prognosis (6 papers), Extracellular vesicles in disease (3 papers) and Circular RNAs in diseases (3 papers). Qiang Song is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Extracellular vesicles in disease (3 papers) and Circular RNAs in diseases (3 papers). Qiang Song collaborates with scholars based in China. Qiang Song's co-authors include Rui Zhou, Fangpeng Shu, Jie Han, Haiwei Yang, Hao Yu, Zhi Hu, Xiaojun Bai, Fenling Fan, Jun Wang and Xiao Yang and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Qiang Song

12 papers receiving 374 citations

Hit Papers

Cuproptosis scoring system to predict the clinical outcom... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiang Song China 9 264 192 114 56 44 13 375
Shiyong Xin China 11 271 1.0× 232 1.2× 104 0.9× 32 0.6× 23 0.5× 30 382
Lang Liu China 12 219 0.8× 159 0.8× 82 0.7× 33 0.6× 60 1.4× 33 370
Xiaoxuan Zhong China 9 246 0.9× 176 0.9× 179 1.6× 28 0.5× 33 0.8× 11 358
Xiaohuan Tang China 8 236 0.9× 208 1.1× 91 0.8× 40 0.7× 33 0.8× 14 343
Jun Meng China 11 184 0.7× 136 0.7× 75 0.7× 42 0.8× 61 1.4× 23 392
Yusho Ishii Japan 7 227 0.9× 139 0.7× 209 1.8× 36 0.6× 14 0.3× 14 361
Zhenqiang Gao China 10 155 0.6× 83 0.4× 96 0.8× 28 0.5× 46 1.0× 26 344
Xuan Tao China 9 178 0.7× 111 0.6× 59 0.5× 25 0.4× 41 0.9× 24 339
Shuheng Bai China 10 163 0.6× 131 0.7× 44 0.4× 24 0.4× 47 1.1× 23 279

Countries citing papers authored by Qiang Song

Since Specialization
Citations

This map shows the geographic impact of Qiang Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Song more than expected).

Fields of papers citing papers by Qiang Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Song. The network helps show where Qiang Song may publish in the future.

Co-authorship network of co-authors of Qiang Song

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Song. A scholar is included among the top collaborators of Qiang Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Song. Qiang Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wu, Huimin, Qiang Song, Ye Wang, et al.. (2025). Compounds of Plant Origin: The Blue Ocean of Anti‐Helicobacter pylori Medicines. Phytotherapy Research. 39(9). 4282–4307.
2.
Song, Qiang, et al.. (2023). A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer. Clinical & Translational Oncology. 25(8). 2587–2606. 8 indexed citations
3.
Lv, Jiancheng, Kai Li, Hao Yu, et al.. (2023). HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway. Journal of Experimental & Clinical Cancer Research. 42(1). 41–41. 64 indexed citations
4.
Song, Qiang, Hao Yu, Yidong Cheng, et al.. (2022). Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment. Journal of Translational Medicine. 20(1). 308–308. 43 indexed citations
5.
Song, Qiang, Hao Yu, Jie Han, et al.. (2022). Exosomes in urological diseases - Biological functions and clinical applications. Cancer Letters. 544. 215809–215809. 18 indexed citations
7.
Song, Qiang, et al.. (2022). Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer. Frontiers in Immunology. 13. 958368–958368. 111 indexed citations breakdown →
8.
Song, Qiang, Hao Yu, Yidong Cheng, et al.. (2022). Bladder Cancer-Derived Exosomal KRT6B Promotes Invasion and Metastasis by Inducing EMT and Regulating the Immune Microenvironment. SSRN Electronic Journal. 3 indexed citations
9.
Lv, Jiancheng, Qiang Song, Jie Han, et al.. (2022). N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer. Cancer Cell International. 22(1). 301–301. 8 indexed citations
10.
Li, Mingzhe, et al.. (2022). Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma. Frontiers in Pharmacology. 13. 992431–992431. 8 indexed citations
11.
Zhou, Zijian, et al.. (2022). Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer. Cancers. 14(12). 2938–2938. 10 indexed citations
12.
Wang, Jun, et al.. (2015). miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages. International Journal of Molecular Sciences. 16(10). 24965–24982. 83 indexed citations
13.
Chen, Chen, Wen Wang, Ming Hou, et al.. (2011). [Monitoring of plasma concentration of imatinib mesylate in patients with chronic myeloid leukemia].. PubMed. 32(7). 450–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026